A synthetic peptide is almost never supplied as the bare molecule. Charged side chains and the free N-terminus pair up with small negatively charged ions, called counterions, and those ions stay in the vial with the peptide after it is dried. The two counterions researchers see most often on a product label or certificate are trifluoroacetate (TFA) and acetate. That is why some products carry names such as “thymosin beta-4 acetate”.
The counterion is easy to overlook, but it affects how much peptide is actually in a vial, how the material behaves in some assays and how certain spectra look. This guide explains acetate vs TFA peptide salts from a laboratory perspective: where each comes from, what changes between them and how to read the information on documentation.
Why Synthetic Peptides Carry a Counterion
Most research peptides are made by solid-phase peptide synthesis (SPPS). In the most common chemistry, the finished chain is cut from the resin and its protecting groups are removed with concentrated trifluoroacetic acid. The crude peptide is then purified by reversed-phase HPLC, where the mobile phase usually contains a small amount of TFA (often around 0.1%) to sharpen the peaks.
After purification, the fractions are freeze-dried. Free TFA evaporates, but TFA that is ionically bound to positively charged groups does not. Basic residues (lysine, arginine, histidine) and the free amino terminus all carry a positive charge under acidic conditions, and each of them can hold a trifluoroacetate ion. The result is a peptide TFA salt. A recent consensus review in Pharmaceuticals notes that TFA is the default counterion for most synthetic peptides precisely because of these synthesis and purification steps (Pharmaceuticals, 2025).
An acetate salt is made by replacing the trifluoroacetate with acetate, the conjugate base of acetic acid, in an extra step after purification. Hydrochloride (HCl) salts are a third common option.
Acetate vs TFA at a Glance
| Factor | TFA salt | Acetate salt |
|---|---|---|
| Origin | Default result of SPPS cleavage and TFA-containing HPLC | Made by exchanging the TFA after purification |
| Counterion mass | Trifluoroacetate, about 113 g/mol | Acetate, about 59 g/mol |
| Extra processing | None | Ion exchange or repeated lyophilization; some yield loss |
| Acid strength of parent acid | Strong (pKa about 0.2-0.5) | Weak (pKa about 4.76) |
| Possible assay effects | Reported effects in some cell-based assays | Generally considered more neutral |
| Spectroscopy | Strong infrared band that overlaps the amide I region | Smaller interference |
| Typical cost | Lower | Higher |
What the Counterion Changes in the Lab
1. Net peptide content
The powder in a vial is not 100% peptide. It contains the peptide, its counterions and some residual water. Net peptide content is the share of the powder mass that is the peptide itself. It is often in the range of roughly 60-90% for a typical lyophilized peptide, depending on sequence and processing.
Counterions are a large part of that gap. A peptide with several basic residues can carry several trifluoroacetate ions, and at about 113 g/mol each they add noticeable mass. Acetate is lighter, so the same peptide as an acetate salt usually has a somewhat higher peptide fraction per milligram of powder.
This is separate from HPLC purity. Purity describes how much of the peptide material is the correct sequence compared with related impurities. Net peptide content describes how much of the powder is peptide at all. A product can be 99% pure by HPLC and still be 75% peptide by weight. When a solution needs a precise molar concentration, both numbers matter. The peptide calculator and the guide to calculating peptide concentration work from the mass you enter, so use the peptide mass rather than the powder mass when net content is known.
2. Cell-based and biological assays
Residual trifluoroacetate has been reported to influence some cell-based experiments, including proliferation and viability readouts, at concentrations that can be reached when a TFA salt is dissolved at high peptide concentrations. The effect depends on the cell type, the assay and the amount of peptide used, and not every study finds an effect. Because of this uncertainty, many researchers prefer acetate or hydrochloride salts for cell work, or run a matched TFA control. The Pharmaceuticals review discusses these reports and recommends that the counterion and its amount be stated so results can be compared across labs (Pharmaceuticals, 2025).
3. pH of unbuffered solutions
Trifluoroacetic acid is a much stronger acid than acetic acid. If a TFA salt is dissolved in plain water with no buffer, the solution can be noticeably more acidic than the same peptide as an acetate salt. In buffered systems the difference is usually small, but it is worth checking when an experiment is pH sensitive.
4. Infrared and circular dichroism spectra
Trifluoroacetate absorbs strongly in the infrared near 1670 cm⁻¹, which falls inside the amide I band used to study peptide secondary structure. For FTIR work on structure, a TFA salt can distort the reading unless the counterion is removed or subtracted. It can also interfere with some circular dichroism measurements at low wavelengths.
5. Solubility and handling
The counterion can change how readily a peptide dissolves and how hygroscopic the powder is. Neither salt is always better. Solubility depends mainly on the sequence, and the counterion shifts it at the margins. See lyophilized vs liquid peptides for storage and handling of the dry powder.
How TFA Is Exchanged for Acetate
Several lab methods are used to swap the counterion. Common approaches include:
- Ion-exchange chromatography. The peptide is passed through an anion-exchange resin loaded with acetate, which captures trifluoroacetate and releases acetate in its place.
- Repeated lyophilization from dilute acid. The peptide is dissolved in dilute hydrochloric or acetic acid and freeze-dried, several times. The stronger acid displaces trifluoroacetate, which leaves as volatile TFA. HCl is the more effective of the two for this.
- Reversed-phase HPLC with an acetate mobile phase. The peptide is bound to the column, washed with an acetate-containing buffer and eluted, so it comes off as the acetate salt.
Each method costs time and some peptide, which is why acetate salts are usually priced higher. Exchange is also rarely 100% complete, so a small residual TFA level can remain.
Residual TFA can be measured by ion chromatography, ¹⁹F NMR or other methods. The consensus review compares these and argues for more consistent reporting of the counterion and its amount (Pharmaceuticals, 2025).
Reading Counterion Information on Documentation
When comparing products or suppliers, look for:
- The salt form in the product name or COA. “Acetate” or “HCl” means an exchange step was done. If no salt is named, assume TFA.
- Molecular weight. Check whether the stated molecular weight is for the free peptide or for the salt. They differ, and the difference matters for molar calculations.
- Net peptide content, if reported, which is usually based on amino acid analysis or nitrogen analysis.
- HPLC purity and mass spectrometry identity. These confirm the peptide itself, not the counterion. The guide to reading a certificate of analysis explains each section.
- Residual TFA, if stated, for acetate or HCl salts.
The vendor evaluation checklist covers what else to ask for. Published certificates and supplier test reports are on the COA page.
Example: Thymosin Beta-4 Acetate
Thymosin beta-4 is a 43-residue peptide with several lysine residues, so a TFA salt of it could carry a substantial counterion load. Supplying it as an acetate salt, as with the TB-500 / thymosin beta-4 acetate product, reduces the counterion mass and avoids TFA-related questions in downstream work. The same identity and purity checks still apply.
Which Salt Form Should a Lab Choose?
There is no single answer. A TFA salt is usually adequate for analytical work, method development or experiments where the counterion is known not to interfere. An acetate or HCl salt is often preferred for cell-based assays, structural spectroscopy and any work where results will be compared across labs. Whatever the salt, record it in the lab notebook along with the lot number, purity and net peptide content, so the result can be reproduced.
Frequently Asked Questions
What is the difference between acetate and TFA peptide salts?
Both are counterions bound to positively charged groups on the peptide. TFA (trifluoroacetate) is left behind by standard synthesis and HPLC purification. Acetate is introduced by an extra exchange step that replaces the TFA.
Why do most synthetic peptides come as TFA salts?
Trifluoroacetic acid is used to cleave the peptide from the synthesis resin and is added to the HPLC mobile phase during purification. Ionically bound trifluoroacetate survives freeze-drying, so TFA is the default salt unless an exchange is done.
Does the counterion change the peptide’s purity?
No. HPLC purity measures the share of correct-sequence peptide versus related impurities. The counterion affects net peptide content, which is the share of the powder mass that is peptide.
Can residual TFA affect an experiment?
It can in some cases. TFA has been reported to influence some cell-based assays and interferes with infrared spectra in the amide I region. Many researchers choose acetate or HCl salts, or run TFA controls, for sensitive work.
How is TFA removed from a peptide?
Common methods are ion-exchange chromatography with an acetate resin, repeated lyophilization from dilute hydrochloric or acetic acid, and reversed-phase HPLC with an acetate buffer. A small residual amount often remains.
For research use only. Not for human or veterinary use.